In vivo effect of haemodilution with saline on coagulation EditorÐAs the in¯uence of i.v.¯uids on the coagulation system is of importance and also sustains the discussion on optimal¯uid therapy, we would like to comment on the results reported by Ng and colleagues 1 and the suggestions presented in the accompanying editorial.
First, the ratio of blood withdrawn:replacement with normal saline was 1:2, which suggests that the haemodiluted patients were hypovolaemic rather than haemodiluted. Second, all study subjects were patients with malignant disease, who are known to exhibit some state of hypercoagulability because of their underlying disease. Third, the shortening of the reaction time (rtime) by 30% and the coagulation time (k-time) by 36±45% was statistically different from the controls, but they also showed prolongation of the r-and k-times, although no intervention occurred. The question arises as to whether such changes are relevant in vivo, as they might be explained as an in vitro phenomenon attributable to sedimentation of red cells in the thrombelastograph (TEG) cup. Uraemic patients have been shown to have an increased bleeding time, but also exhibit thrombelastographic signs of hypercoagulability measured by shorter r-and ktimes, increased a-angle and maximum amplitude compared to normal controls.
3 Interestingly, the latter study showed a signi®cant negative correlation between haematocrit and signs of hypercoagulability. Moreover, isolated reduction of the haematocrit from 40 to 10% also resulted in thrombelastographic signs of hypercoagulability. 4 Reports of accelerated coagulation during haemodilution might therefore be in¯uenced by changes in red cell sedimentation occurring with changing haematocrit. It is likely that this effect also depends on the physicochemical properties of the dilution¯uid used and the time needed to process the coagulation measurements. Our in vitro and in vivo data on the in¯uence of colloids and crystalloids on coagulation show an accelerated initiation of coagulation during moderate haemodilution with Ringer's lactate and gelatin for the slow-reacting intrinsic TEG measurements only. 5 6 In contrast to the data of Ng 1 and Ruttmann, 2 our results for accelerated coagulation were always accompanied by a reduction in clot ®rmness. Furthermore, we were surprised that, in the study by Ng and colleagues, the aangle increased by about 71% in the haemodiluted group at 30 min, although platelets and ®brinogen decreased markedly. Given a normal value of 60°, this would mean that the angle would have reached values well above 90°. Was this really observed? Analysis of our in vivo data for the a-angle showed no signi®cant difference in the intraoperative response pro®le (area under the curve minus baseline, AUC A-D ) of extrinsic TEG measurements between different¯uid regimens (hydroxyethyl starch, modi®ed gelatin 4% combined with a basal infusion of Ringer's lactate, or Ringer's lactate), and a signi®cant difference in intrinsic TEG tracings between the two colloid groups only (Table 1) .
Another question arises concerning measurements of concentrations of thrombin±antithrombin complexes (TAT). Why were concentrations of TAT much higher in the control group, and why did they also show a large standard deviation not observed in the haemodiluted group? Despite these inter-group discrepancies, the authors assumed that thrombin generation was increased in their haemodiluted patients as concentrations of TAT did not change during haemodilution, but showed an insigni®cant decrease in the controls.
A clinical study investigated coagulation after haemodilution with gelatin (in addition to a basal infusion of Ringer's lactate), which has also been associated with signs of hypercoagulability.
7
In this study, concentrations of TAT did not change signi®cantly over several hours in haemodiluted or control patients. Yet 3 h after surgery, a signi®cant increase was observed, but only in control patients. Furthermore, all measurements of activated coagulation and ®brinolysis showed no differences between groups.
In summary, there is very little evidence that administration of i.v.¯uids leads to clinically detectable hypercoagulability. Data from one study conducted in 1980, investigating only 30`wet' and 30`dry' patients during abdominal surgery without perioperative thrombosis prophylaxis, are insuf®cient to associate i.v.¯uid therapy with development of deep venous thrombosis.
2 8 Some data indicate that the impairment of coagulation is the least when predominantly crystalloids are used.
5 6 These effects are seen as an advantage for surgical patients with respect to preventing further blood loss and limiting the need for transfusion of blood products. Moreover, reports on disseminated intravascular coagulopathy after administration of crystalloids are lacking in the literature. In vivo, the response of the coagulation system is mainly governed by the extrinsic pathway. Therefore, the impact of TEG measurements which are obtained without extrinsic activation, thus depending on the reactions provoked by contact to foreign surfaces, remains to be determined.
Until it is proven clearly that hypercoagulability measured by TEG is not only an in vitro phenomenon but also relevant in vivo, it seems dangerous to recommend withholding i.v.¯uids. Normovolaemia is essential for maintaining suf®cient oxygen delivery to the tissues, and thus¯uid therapy, not only in¯uences coagulation, but also preserves organ function.
EditorÐThank you for the opportunity to reply to the letter by Dr Innerhofer and colleagues commenting on our paper. 1 We acknowledge Dr Innerhofer's point that the clinical signi®cance of the hypercoagulability caused by crystalloid infusion remains to be evaluated. However, we believe that, given the prospective, randomized and controlled design, it is safe to state that our study is without the effect of any confounding variables.
We cannot agree with Dr Innerhofer that, because replacement with saline was 1:2, patients in the haemodiluted group in our study were hypovolaemic. The usual 25±30% retention rule is oversimpli®ed and refers to an equilibrium state only. The percentage retention of infused crystalloid in the intravascular compartment is dynamic. It depends upon the volume infused, the rate of infusion, and on when one is making the measurement. This has been discussed elegantly by Hahn and colleagues. 9 As we were allowing only 10 min for the infused¯uid to distribute in our study procedure, 1:2 is the ratio administered to achieve normovolaemia. In fact, if we assume normovolaemia then the drop in haemoglobin (Hb) concentration after removal of 10, 20 where Hb 10% , 20% , 30% refers to the Hb concentration after removal of 10, 20 and 30% of blood volume and concomitant isovolaemic haemodilution. Hb 0 is the initial Hb concentration. In other words, the Hb concentration after removal of 10, 20 and 30% of blood volume should be 0.90 Hb 0 , 0.82 Hb 0 and 0.74 Hb 0 respectively. In our study, the values were 0.90, 0.80 and 0.74 respectively, which con®rmed almost exact isovolaemia. Dr Innerhofer's suggestion that the shortening of r-and k-times might be an artefact related to changes in red cell sedimentation is interesting, as they reported the effect may disappear when the TEG measurement was made more quickly. However, to accelerate measurement, the differences one would have to introduce are more than just the cell sedimentation rate. Certain components of the coagulation process would invariably be suppressed or enhanced. The differences in TEG variables one observes may not be attributable to differences in measurement time alone. The fact that an isolated reduction of haematocrit resulted in hypercoagulability 4 only proved that haemodilutionrelated hypercoagulability could develop in the absence of changes in concentrations of natural procoagulants or anticoagulants. It cannot be interpreted that the hypercoagulability is because of changes in red cell sedimentation during measurement, nor can the results exclude the possible contribution of changes in concentrations of natural procoagulants or anticoagulants.
We are surprised that Dr Innerhofer quoted the normal value of a as 60°, which, as far as we know, is usually quoted between 29 and 43°for native TEG. 11±13 In our study, the pre-dilution value of a was 26°in the haemodiluted group, increasing to 43°at 15 min, a 70% increase.
The higher mean and variance in the TAT concentrations of the control group were because of two patients with high TAT concentrations in this group. Thus, the two groups may not be comparable directly with respect to TAT concentrations and, therefore, this was not attempted. What we have done is to follow the trend of TAT concentration in each group over time. Our suggestion that thrombin generation may be increased in the haemodiluted group was based on the lack of decline in TAT concentration despite haemodilution and a proportional decline in other haemostatic and cellular markers within this group.
We fully agree with Dr Innerhofer that the native TEG is mainly measuring the contact activation (intrinsic) pathway of coagulation. Therefore the study, which demonstrated TEG features of hypercoagulability and yet prolonged bleeding time, 3 could not be simply discarded as reporting an artefact in the TEG measurement. The TEG is not a monitor of platelet function. Bleeding time measures adhesive properties of platelets (platelet±vWF±endothelium interaction) which is the major haemostatic defect observed in uraemic patients.
14 Although TEG variables are affected by thrombocytopenia, interestingly, the addition of platelets that are totally incapable of adhesion or aggregation improves the TEG, and the possible mechanisms for this have been reported. 15 Similarly, because TEG measures mainly the contact activation pathway, it is true that the clinical signi®cance of our observation remains to be evaluated. We also agree that the patients we have studied probably had some pre-existing hypercoagulability. However, because of the parallel design of the study, this effect should be roughly similar in the haemodiluted and control groups. Being aware of these limitations, and with our total agreement with Dr Innerhofer on the importance of adequate circulating volume, it has never been our intention to advocate withholding i.v. crystalloids from surgical patients. We shall need properly designed outcome studies to address this issue. Quality of pre-hospital emergency ventilation in patients with severe head injury
EditorÐWe would like to comment on the article by Helm and colleagues, 1 in which two speci®c outcomes of out-of-hospital ventilation, oxygenation and ventilation are investigated. The article concluded that tracheal intubation and controlled ventilation in the pre-hospital setting do not guarantee optimal oxygenation or ventilation. Optimal oxygenation was achieved in 85.2% of patients. In 1996, Stocchetti and Furlan 2 demonstrated that 57% of patients with head trauma had an arterial oxygen saturation <90% at the scene of the accident. If this patient group is similar, the system that Helm and colleagues describe provides excellent improvement in the on-scene oxygenation of headinjured patients, especially as some of the poorly oxygenated patients had signi®cant chest injuries and might well have been dif®cult to oxygenate, even in the hospital intensive care setting. With regard to`adequate ventilation', we accept that, while capnography can be dif®cult to interpret in the hypovolaemic patient or those with severe lung contusion, it still provides invaluable information. In addition to providing evidence of appropriate ventilation, capnography also provides con®rmation of tracheal intubation and detection of disconnection. Both the Intensive Care Society, 3 and the Association of Anaesthetists, 4 have produced guidelines for transfer of the critically ill. Both organizations advise the use of capnography. We see no reason why primary transfers of the critically ill should have lower standards than secondary transfers, particularly in doctor-led systems. Lastly, the authors comment that blood gas analysis is the gold standard in ventilatory monitoring, but is impractical in the pre-hospital setting. This is usually the case, but with the advent of hand-held devices that can perform blood gas analysis as well as other blood tests, it may be that in the few patients with prolonged scene times or long transfers, this level of monitoring may become practical.
EditorÐFirst of all, we would like to thank Drs Richards and Lockey for their comments on our article. 1 We agree totally with their recommendations and have followed them on a routine basis in our emergency medical service in Ulm, Germany for 3 yr! With regard to`adequate ventilation', capnography can be dif®cult to interpret in the hypovolaemic trauma patient or those with severe lung contusion.
5 6 The use of capnography for controlling arti®cial ventilation is therefore limited in this group of trauma patients. However, we agree that capnography provides con®rmation of tracheal intubation and detection of disconnection, and that its routine use should be recommended as a monitor of safety in ventilated patients in the pre-hospital setting. Capnography has been mandatory in any ventilated patient received into our emergency medical service for nearly 3 yr.
Blood gas analysis is the gold standard in ventilatory monitoring. In the pre-hospital setting, especially in primary rescue missions of traumatized patients, it seems to be impractical as a monitoring method on a routine basis because it is invasive, time-consuming and non-continuous. Again we agree with Drs Richards and Lockey when they recommend blood gas analysis in the few cases with prolonged scene times or long transfers. We have been performing blood gas analysis, as well as determination of haematocrit and plasma electrolytes, in such cases using a hand-held blood gas analyser (i-Stat; Hewlett Packard) on a routine basis for more than 2 yr.
M. Helm
Ulm, Germany Mechanical closure of the vocal cords with the LMA ProSealÔ
EditorÐI was interested to read the case report by Brimacombe and colleagues 1 listing the features of the LMA ² ProSealÔ together with the insertion problems ascribed to its bulky nature. The recently introduced Airway Management Device (AMDÔ) was designed to address the same shortcomings associated with the LMA ClassicÔ, whilst allowing easy and less traumatic insertion.
2 3
The mechanical closure described by Brimacombe is explained in detail, 1 and corroborates a similar phenomenon seen when using a pre-production prototype in an early stage of the development of the AMDÔ. Before the development of thè arrow-head shape' of the currently available device, the anteroposterior diameter of the in¯ated lower cuff with its unique central drainage channel was some 50% greater. Over-enthusiastic insertion and in¯ation of this cuff beyond its optimal position resulted in near complete airway obstruction, presumably of similar aetiology (i.e. forward displacement of the glottic inlet). As stated, the application of cricoid pressure with the classic LMA simulates the same conditions. 4 The less bulky nature of the AMDÔ should not cause such compression opposite the glottic inlet. The slim anteroposterior pro®le of the lower cuff, when in¯ated before insertion, greatly ² LMA â is the property of Intavent Limited.
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